Supreme Court Eyes Glaxo's Paxil Appeal

Law360, New York (January 9, 2006, 12:00 AM EST) -- In a fresh sign that intellectual property matters will weigh heavily at the U.S. Supreme Court this year, justices have asked the Bush administration's solicitor general for advice while considering the appeal of U.K. drug maker GlaxoSmithKline Plc over its antidepressant Paxil.

Glaxo’s subsidiary SmithKline Beecham Corp. sued Canadian generic drug maker Apotex Inc. in 1998 over its attempt to make a generic version of the popular drug. The suit was filed in the U.S. District Court for the Northern District of Illinois, which ruled in...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.